Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 4
2014 1
2015 6
2016 8
2017 12
2018 9
2019 7
2020 14
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis.
Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H, Hohensinner P, Basílio J, Petzelbauer P, Assinger A, Schmid JA. Mussbacher M, et al. Among authors: schoergenhofer c. Front Immunol. 2019 Feb 4;10:85. doi: 10.3389/fimmu.2019.00085. eCollection 2019. Front Immunol. 2019. PMID: 30778349 Free PMC article. Review.
Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.
Gelbenegger G, Schoergenhofer C, Derhaschnig U, Buchtele N, Sillaber C, Fillitz M, Schenk TM, D'Sa S, Cartwright R, Gilbert JC, Jilma B, Jaeger U. Gelbenegger G, et al. Among authors: schoergenhofer c. Blood Adv. 2020 Mar 24;4(6):997-1005. doi: 10.1182/bloodadvances.2019001321. Blood Adv. 2020. PMID: 32176765 Free PMC article. Clinical Trial.
A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway.
Bartko J, Schoergenhofer C, Schwameis M, Firbas C, Beliveau M, Chang C, Marier JF, Nix D, Gilbert JC, Panicker S, Jilma B. Bartko J, et al. Among authors: schoergenhofer c. Clin Pharmacol Ther. 2018 Oct;104(4):655-663. doi: 10.1002/cpt.1111. Epub 2018 Jul 13. Clin Pharmacol Ther. 2018. PMID: 29737533 Free PMC article. Clinical Trial.
PCSK9 decreases during experimental endotoxemia.
Schoergenhofer C, Matzneller P, Mühlbacher J, Hell L, Zeitlinger M, Jilma B. Schoergenhofer C, et al. J Intern Med. 2020 Mar;287(3):333-335. doi: 10.1111/joim.13003. Epub 2019 Nov 14. J Intern Med. 2020. PMID: 31660669 No abstract available.
Endpoints for randomized controlled clinical trials for COVID-19 treatments.
Dodd LE, Follmann D, Wang J, Koenig F, Korn LL, Schoergenhofer C, Proschan M, Hunsberger S, Bonnett T, Makowski M, Belhadi D, Wang Y, Cao B, Mentre F, Jaki T. Dodd LE, et al. Among authors: schoergenhofer c. Clin Trials. 2020 Oct;17(5):472-482. doi: 10.1177/1740774520939938. Epub 2020 Jul 16. Clin Trials. 2020. PMID: 32674594 Review.
Chikungunya vaccines in development.
Schwameis M, Buchtele N, Wadowski PP, Schoergenhofer C, Jilma B. Schwameis M, et al. Among authors: schoergenhofer c. Hum Vaccin Immunother. 2016 Mar 3;12(3):716-31. doi: 10.1080/21645515.2015.1101197. Hum Vaccin Immunother. 2016. PMID: 26554522 Free PMC article. Review.
55 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page